IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,191,000 | -26.0% | 468,538 | -10.0% | 0.40% | -30.2% |
| Q1 2021 | $16,482,000 | +31.0% | 520,595 | +92.0% | 0.57% | +28.3% |
| Q4 2020 | $12,578,000 | +40.9% | 271,073 | 0.0% | 0.44% | +32.3% |
| Q3 2020 | $8,924,000 | +19.9% | 271,073 | 0.0% | 0.33% | +18.0% |
| Q2 2020 | $7,441,000 | +12.4% | 271,073 | +22.6% | 0.28% | -5.4% |
| Q1 2020 | $6,618,000 | -1.8% | 221,073 | -9.2% | 0.30% | +17.3% |
| Q4 2019 | $6,740,000 | +111.6% | 243,483 | +39.1% | 0.26% | +83.5% |
| Q3 2019 | $3,185,000 | -34.7% | 175,012 | -12.1% | 0.14% | -30.2% |
| Q2 2019 | $4,881,000 | +136.6% | 199,073 | -8.2% | 0.20% | +136.9% |
| Q1 2019 | $2,063,000 | +7.4% | 216,908 | 0.0% | 0.08% | +2.4% |
| Q4 2018 | $1,920,000 | -21.3% | 216,908 | 0.0% | 0.08% | -6.8% |
| Q3 2018 | $2,440,000 | +471.4% | 216,908 | +549.5% | 0.09% | +450.0% |
| Q2 2018 | $427,000 | – | 33,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |